News & Updates

In patients with nonmetastatic hepatocellular carcinoma (HCC), treatment with upfront liver transplant or liver transplant with bridge systemic therapy results in significantly better improvements in overall survival (OS) compared with systemic therapy only, according to a study.

Treatment with nipocalimab is safe and helps improve clinical disease activity in patients with moderate-to-severe, active Sjögren's disease, according to the phase II DAHLIAS trial.

A handheld, battery-powered lab-in-tube assay device can deliver accurate tuberculosis (TB) diagnoses in less than an hour, according to a study.

Having both chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) is associated with poorer outcomes and increased healthcare resource use for patients, as suggested in a study.

Treatment with olezarsen significantly reduced triglyceride levels and the risk of acute pancreatitis in patients with severe hypertriglyceridaemia, according to the primary results of the CORE-TIMI 72a and CORE2-TIMI 72b trials presented at AHA 2025.

Colon cancer patients who underwent surgery appear to have worse survival outcomes in the presence of inflammatory bowel disease (IBD), as shown in a study.

Exposure to oral corticosteroids during pregnancy is not associated with the risk of gestational diabetes mellitus (GDM), except for a modest increase during an early exposure window, as shown in a study from South Korea.

In patients with papillary thyroid cancer (PTC), radioactive iodine therapy (RAIT) does not appear to increase the risk of a second primary malignancy (SPM), reports a study. On the other hand, age and personal or family history of cancer are predictive of SPM in this population.